Non-Invasive Monitoring Systems Stock

Non-Invasive Monitoring Systems Revenue

The revenue of Non-Invasive Monitoring Systems (NIMU) as of Aug 17, 2026.

Revenue

0.00USD

Last updated:

In 2026, Non-Invasive Monitoring Systems's sales reached 0.00 USD, a % difference from the 0.00 USD sales recorded in the previous year.

Revenue at Non-Invasive Monitoring Systems has contracted by 30.7% per year over the past 11 years to 6,000.00 USD.

The Non-Invasive Monitoring Systems Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

REVENUE (k USD)
GROSS MARGIN (%)
Date
REVENUE (k USD)
GROSS MARGIN (%)
Jan 1, 2018
0.00 base
0.00 base
Jan 1, 2019
0.00 base
0.00 base
Jan 1, 2020
0.00 base
0.00 base
Jan 1, 2021
0.00 base
0.00 base
Jan 1, 2022
0.00 base
0.00 base
Jan 1, 2023
0.00 base
0.00 base
Jan 1, 2024
0.00 base
0.00 base
Jan 1, 2025
0.00 base
0.00 base
YEARREVENUE (k USD)GROSS MARGIN (%)
2025 --
2024 --
2023 --
2022 --
2021 --
2020 --
2019 --
2018 --
2017 6.00-1,566.67
2016 23.00-1,360.87
2015 --
2014 10.00100.00
2013 110.0063.64
2012 250.0092.00
2011 740.0077.03
2010 620.0059.68
2009 550.0054.55
2008 300.0093.33
2007 310.0096.77
2006 340.0085.29
Access this data via the Eulerpool API

Non-Invasive Monitoring Systems Revenue

Non-Invasive Monitoring Systems Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2018
0.00 USD
-178,000.00 USD
-445,000.00 USD
Jan 1, 2019
0.00 USD
-446,000.00 USD
-1.62 M USD
Jan 1, 2020
0.00 USD
-165,000.00 USD
-163,000.00 USD
Jan 1, 2021
0.00 USD
-158,000.00 USD
-158,000.00 USD
Jan 1, 2022
0.00 USD
-159,000.00 USD
-173,000.00 USD
Jan 1, 2023
0.00 USD
-169,000.00 USD
-199,000.00 USD
Jan 1, 2024
0.00 USD
-177,000.00 USD
-113,000.00 USD
Jan 1, 2025
0.00 USD
-160,000.00 USD
-222,000.00 USD

Non-Invasive Monitoring Systems Margins

Non-Invasive Monitoring Systems stock margins

The Non-Invasive Monitoring Systems margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Non-Invasive Monitoring Systems. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Non-Invasive Monitoring Systems.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2018
-1,566.67 %
- %
- %
Jan 1, 2019
-1,566.67 %
- %
- %
Jan 1, 2020
-1,566.67 %
- %
- %
Jan 1, 2021
-1,566.67 %
- %
- %
Jan 1, 2022
-1,566.67 %
- %
- %
Jan 1, 2023
-1,566.67 %
- %
- %
Jan 1, 2024
-1,566.67 %
- %
- %
Jan 1, 2025
-1,566.67 %
- %
- %

Non-Invasive Monitoring Systems Stock analysis

What does Non-Invasive Monitoring Systems do? Non-Invasive Monitoring Systems Inc (NIMS) has become a major player in the field of medical diagnostics and monitoring in recent years. The company was founded in 2002 and is headquartered in Miami, Florida. Its focus is on developing and marketing innovative non-invasive technologies that enable better patient care. NIMS' business model is based on the development and marketing of products that allow for fast and accurate diagnosis of various medical conditions. These technologies can be used in various clinical areas such as intensive care, oncology, cardiology, and neurology. The company's goal is to improve patient care by making diagnostics and monitoring faster, more accurate, and more effective. NIMS has several divisions that focus on different medical applications. One of these is the gastrointestinal division, which specializes in the diagnosis and monitoring of gastrointestinal disorders. NIMS offers innovative technologies such as magnetic resonance elastography (MRE-MRI), which allows for the measurement of tissue hardness without invasive procedures. This technology is particularly used in the early detection of cancer, as it enables the detection of tissue changes at an early stage. Another important division of NIMS is cardiovascular monitoring, which aims at the early detection and monitoring of heart diseases. The company offers various non-invasive technologies for this purpose, such as wearable devices for measuring blood pressure and heart rate, or ultrasound for measuring blood flow and vascular stiffness. These technologies are intended to improve the monitoring of patients with heart diseases and to detect complications at an early stage. NIMS also offers innovative diagnostic tools for the early detection of cancer, such as the Cancer Screening Index (CSI). The CSI is a biomarker-based test that calculates the probability of developing certain types of cancer. Various factors such as family history, smoking, or age are taken into account in the calculation. The CSI aims to contribute to the early detection of cancer and thus enable better prognosis. In addition to these products, NIMS is also involved in clinical research. The company offers specialized services such as conducting clinical trials or providing expert opinions. These services are intended to promote the development of new non-invasive diagnostic and monitoring technologies and thus improve overall patient care. Overall, NIMS has become a leading company in the field of non-invasive medical diagnostics and monitoring. The company is constantly striving to advance the development of new innovative technologies to improve patient care and minimize the use of invasive procedures. With its various divisions and products, NIMS is able to cover various medical applications and thus appeal to a broad customer base. Non-Invasive Monitoring Systems is one of the most popular companies on Eulerpool.

Revenue Details

Understanding Non-Invasive Monitoring Systems's Sales Figures

The sales figures of Non-Invasive Monitoring Systems originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Non-Invasive Monitoring Systems’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Non-Invasive Monitoring Systems's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Non-Invasive Monitoring Systems’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Non-Invasive Monitoring Systems stock

On Eulerpool you can find the complete historical development of The revenue Non-Invasive Monitoring Systems since 2006 – with annual values, charts, and detailed analysis.

Revenue is the total value of all goods sold in a period. It is calculated by multiplying the quantity of each product sold by its selling price. Revenue does not include any costs (material costs, personnel costs, etc.), whereas net proceeds only deduct revenue reductions associated with the sale (discounts, etc.).

The revenue's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The revenue's Non-Invasive Monitoring Systems historically and in real time.

The revenue in assessing a stock

Revenue is an important financial measure used in the valuation of stocks. It is a measure of a company's economic activity and can serve as an indicator of the company's success. Revenue is considered one of the most important factors in stock valuation. In addition, revenue can also be used to calculate other financial measures such as earnings per share and price-earnings ratio.

History and utilization of revenue

Revenue has long been considered one of the most important financial indicators. It was used in the 19th century as one of the first financial indicators to measure a company's economic activity. Since then, revenue has been regularly used to evaluate companies.

Revenue is usually calculated as a percentage of the company's equity. It can also be used to determine the overall profitability of a company. There are many different types of revenue that can be used to measure a company's economic activity, such as gross revenue, net revenue, and revenue from international business.

The revenue can also be used to evaluate stocks. For example, the revenue of a company can be used to evaluate the success of the company. If a company has high revenue, it means that it is a profitable company because it has high demand for its products or services.

Calculation and Application of Revenue

In order to calculate a company's revenue, the company's income must be deducted from its expenses. The income can come from various sources, such as sales, licensing fees, services, etc. The expenses can include costs for production, procurement, inventory, sales, and administration.

The revenue can then be used to calculate various financial ratios. For example, the revenue can be used to calculate the price-earnings ratio (P/E ratio) of a company. This is a measure of a company's profitability, calculated by taking the ratio of the stock price to earnings per share.

Revenue can also be used to calculate earnings per share (EPS) of a company. This is a measure of a company's profit per share. EPS is calculated by dividing earnings by the number of shares issued.

Use of revenue by investors

Investors use revenue to evaluate stocks, as revenue is an indicator of a company's success. For example, an investor can compare a company's revenue to see how successful it is. An investor can also use a company's revenue to calculate its price-to-earnings ratio and earnings per share.

An example: An investor looks at a company that has a revenue of 25 million euros. He compares this revenue to that of the competitor, which has a revenue of 35 million euros. The investor can then see that the company with 25 million euros in revenue is less successful than the company with 35 million euros in revenue.

Advantages and Disadvantages of Revenue.

Revenue is a very useful tool for valuing stocks as it measures a company's economic activity. Revenue can also be used to calculate other financial ratios such as the price-earnings ratio and earnings per share.

However, one disadvantage is that revenue alone is not a meaningful indicator of a company's success. It is important to consider revenue in comparison to other financial metrics such as earnings per share and price-to-earnings ratio to get a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Non-Invasive Monitoring Systems

All Key Metrics — Non-Invasive Monitoring Systems